LEOMINSTER, MA — Federal health inspectors identified five deficiencies at Keystone Center during a standard health inspection in November 2025, including a pharmacy service citation for failures in drug labeling and controlled substance storage that carried potential for resident harm.
Drug Labeling and Storage Failures
During the November 19, 2025 inspection, surveyors cited Keystone Center under federal regulatory tag F0761, which governs how nursing facilities handle pharmaceutical labeling and secure storage of medications.
Specifically, inspectors found the facility failed to ensure that drugs and biologicals were labeled in accordance with accepted professional standards. Additionally, the facility did not maintain proper locked storage for all medications, including the requirement that controlled substances be kept in separately locked compartments.
The deficiency was classified at Scope/Severity Level E, indicating a pattern of noncompliance rather than an isolated incident. While inspectors documented no actual harm to residents at the time of the survey, the classification noted potential for more than minimal harm — a designation that signals real risk to resident safety.
Why Proper Drug Storage Matters
Medication management in nursing homes is one of the most fundamental safety requirements in long-term care. Proper labeling ensures that staff administer the correct medication, at the correct dose, to the correct resident. When labels are missing, damaged, or inconsistent with professional standards, the risk of medication errors increases significantly.
Medication errors in nursing homes can lead to adverse drug reactions, overdoses, underdoses, dangerous drug interactions, and in the most serious cases, life-threatening emergencies. Elderly residents are particularly vulnerable because they typically take multiple medications simultaneously and their bodies metabolize drugs differently than younger patients.
The requirement for locked storage of controlled substances — such as opioid pain medications, benzodiazepines, and certain sleep aids — exists for equally critical reasons. Controlled substances carry risks of diversion, misuse, and accidental exposure. When these medications are not stored in separately locked compartments, they become accessible to unauthorized individuals, increasing the potential for drug diversion by staff or accidental ingestion by residents.
Federal regulations under 42 CFR §483.45 require that nursing facilities maintain pharmaceutical services that meet the needs of each resident. This includes proper storage conditions that protect drug integrity and prevent unauthorized access. Industry best practices call for daily medication storage audits, temperature monitoring, and routine checks of labeling compliance.
A Pattern of Noncompliance
The Level E classification is particularly notable because it indicates the drug storage and labeling issues were not a one-time oversight. A pattern designation means inspectors found the problem across multiple instances, locations, or timeframes within the facility. This suggests a systemic gap in the facility's pharmacy management protocols rather than a single staff member's mistake.
Keystone Center reported correcting the deficiency as of December 3, 2025, approximately two weeks after the inspection. The facility's correction plan would typically include measures such as re-labeling all improperly marked medications, securing controlled substances in compliant locked compartments, retraining pharmacy and nursing staff on storage protocols, and implementing audit procedures to prevent recurrence.
Five Total Deficiencies
The drug storage citation was one of five deficiencies identified during the November 2025 inspection. Multiple citations during a single survey often point to broader operational or staffing challenges within a facility.
Keystone Center, located in Leominster, Massachusetts, is subject to ongoing federal oversight as a Medicare- and Medicaid-certified nursing facility. Facilities that receive federal funding must comply with the Centers for Medicare & Medicaid Services (CMS) conditions of participation, which include strict pharmaceutical service standards.
Families with loved ones at Keystone Center can review the facility's full inspection history, including all five deficiencies from the November 2025 survey, through the CMS Care Compare database. Residents and their advocates are encouraged to ask facility administrators about corrective actions taken and any updated medication management procedures now in place.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Keystone Center from 2025-11-19 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.